Mainstream

Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance

Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance

Post ContentomerRead More

You might also be interested in reading XRP Battle Heats Up—Can Bulls Turn the Tide?.

May 16, 2025
In Mainstream